Joachim Quernheim-Muller

Freiburg, BW 79106, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications

PDE-4 Inhibition in Sarcoidosis Patients: A Retrospective Single-Center Analysis of 51 Patients.

PDE-4 Inhibition in Sarcoidosis Patients: A Retrospective Single-Center Analysis of 51 Patients.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 01, 2025

Response.

Response.

Journal: Chest
Published: August 28, 2025

Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10.

Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10.

Journal: International journal of molecular sciences
Published: February 03, 2025

Additional diagnostic potential of transbronchial lung cryobiopsy in bronchoscopic assessment of sarcoidosis and chronic beryllium disease: a retrospective analysis of 321 patients.

Additional diagnostic potential of transbronchial lung cryobiopsy in bronchoscopic assessment of sarcoidosis and chronic beryllium disease: a retrospective analysis of 321 patients.

Journal: BMJ open respiratory research
Published: February 03, 2025

Beryllium Lymphocyte Proliferation Test: Differential Diagnosis of Sarcoidosis and Chronic Beryllium Disease.

Beryllium Lymphocyte Proliferation Test: Differential Diagnosis of Sarcoidosis and Chronic Beryllium Disease.

Journal: Chest
Published: December 14, 2024

Therapeutic Pathways in Sarcoidosis. A Position Paper of the German Society of Respiratory Medicine (DGP)

Therapeutic Pathways in Sarcoidosis. A Position Paper of the German Society of Respiratory Medicine (DGP)

Journal: Pneumologie (Stuttgart, Germany)
Published: February 26, 2024

Corrigendum: Sex differences in the genetics of sarcoidosis across European and African ancestry populations.

Corrigendum: Sex differences in the genetics of sarcoidosis across European and African ancestry populations.

Journal: Frontiers in medicine
Published: February 06, 2024

Pro-Fibrotic Effects of CCL18 on Human Lung Fibroblasts Are Mediated via CCR6.

Pro-Fibrotic Effects of CCL18 on Human Lung Fibroblasts Are Mediated via CCR6.

Journal: Cells
Published: December 01, 2023

Genetic and geographic influence on phenotypic variation in European sarcoidosis patients.

Genetic and geographic influence on phenotypic variation in European sarcoidosis patients.

Journal: Frontiers in medicine
Published: May 11, 2023

Sex differences in the genetics of sarcoidosis across European and African ancestry populations.

Sex differences in the genetics of sarcoidosis across European and African ancestry populations.

Journal: Frontiers in medicine
Published: December 27, 2022

Prevention of M2 polarization and temporal limitation of differentiation in monocytes by extracellular ATP.

Prevention of M2 polarization and temporal limitation of differentiation in monocytes by extracellular ATP.

Journal: BMC immunology
Published: December 19, 2022

Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.

Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.

Journal: Trials
Published: March 30, 2022
Showing 1-12 of 106

Last Updated: 09/26/2026